-
EP2701681
European procedure
Extract from the Register of European Patents
EP About this file: EP2701681
| EP2701681 - PHARMACEUTICAL COMPOSITIONS COMPRISING A LOCAL ANAESTHETIC SUCH AS BUPIVACAINE FOR LOCAL ADMINISTRATION TO THE MOUTH OR THROAT [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.08.2017 Database last updated on 02.11.2024 | Most recent event Tooltip | 03.10.2024 | Change - lapse in a contracting state State(s) deleted from list of lapses: AL | published on 06.11.2024 [2024/45] | Applicant(s) | For all designated states Moberg Pharma AB Gustavslundsvägen 42, 5 tr 167 51 Bromma / SE | [2014/31] |
| Former [2014/10] | For all designated states Oracain II ApS Hvilevej 13 2900 Hellerup / DK | Inventor(s) | 01 /
ANDERSEN, Ove Hvilevej 13 DK-2900 Hellerup / DK | 02 /
MOGENSEN, Stine Offenbachsvej 31 3 DK-2450 København SV / DK | 03 /
TRELDAL, Charlotte Jagtvej 177 4.th DK-2100 København Ø / DK | 04 /
MOGENSEN, Torben Mønstedsvej 5 DK-2670 Greve / DK | 05 /
PULIS, Sylvia Buntmagervej 8 4.tv DK-2400 København NV / DK | [2014/10] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2016/42] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | ||
| Former [2014/10] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham, NG1 5GG / GB | Application number, filing date | 12719345.6 | 27.04.2012 | [2016/42] | WO2012EP57864 | Priority number, date | DK20110070213 | 29.04.2011 Original published format: DK 201170213 | DK20110070225 | 06.05.2011 Original published format: DK 201170225 | [2014/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012146763 | Date: | 01.11.2012 | Language: | EN | [2012/44] | Type: | A1 Application with search report | No.: | EP2701681 | Date: | 05.03.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.11.2012 takes the place of the publication of the European patent application. | [2014/10] | Type: | B1 Patent specification | No.: | EP2701681 | Date: | 19.10.2016 | Language: | EN | [2016/42] | Search report(s) | International search report - published on: | EP | 01.11.2012 | Classification | IPC: | A61K9/00, A61K31/445 | [2014/10] | CPC: |
A61K31/445 (EP,US);
A61K31/167 (EP,US);
A61K45/06 (EP,US);
A61K9/0056 (EP,US);
A61P23/02 (EP)
| C-Set: |
A61K31/167, A61K2300/00 (EP,US);
A61K31/445, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/10] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT EINEM LOKALANÄSTHETIKUM WIE BUPIVACAIN ZUR LOKALEN VERABREICHUNG AN DEN MUND ODER RACHEN | [2014/10] | English: | PHARMACEUTICAL COMPOSITIONS COMPRISING A LOCAL ANAESTHETIC SUCH AS BUPIVACAINE FOR LOCAL ADMINISTRATION TO THE MOUTH OR THROAT | [2014/10] | French: | COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN ANESTHÉSIANT LOCAL TEL QUE DE LA BUPIVACAÏNE POUR ADMINISTRATION DANS LA BOUCHE OU LA GORGE | [2014/10] | Entry into regional phase | 20.11.2013 | National basic fee paid | 20.11.2013 | Designation fee(s) paid | 20.11.2013 | Examination fee paid | Examination procedure | 20.11.2013 | Examination requested [2014/10] | 28.08.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 17.10.2014 | Amendment by applicant (claims and/or description) | 04.05.2016 | Communication of intention to grant the patent | 26.05.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 17.06.2016 | Communication of intention to grant the patent | 08.09.2016 | Fee for grant paid | 08.09.2016 | Fee for publishing/printing paid | 08.09.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | EP16192891.6 / EP3173069 | EP17189690.5 / EP3284459 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.05.2016 | Opposition(s) | 20.07.2017 | No opposition filed within time limit [2017/39] | Request for further processing for: | 17.10.2014 | Request for further processing filed | 17.10.2014 | Full payment received (date of receipt of payment) Request granted | 23.12.2014 | Decision despatched | Fees paid | Renewal fee | 14.07.2014 | Renewal fee patent year 03 | 10.04.2015 | Renewal fee patent year 04 | 11.04.2016 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.04.2014 | 03 M06 Fee paid on 14.07.2014 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2024/45] |
| Former [2022/31] | AL | 19.10.2016 | Cited in | International search | [Y]WO9742941 (NOVARTIS CONSUMER HEALTH SA [CH], et al) [Y] 5,6,9,11-13 * page 1, paragraph 1 * * pages 2-3 * * page 4, lines 10-11, paragraph 1 * * page 4, paragraphs 2-3 *; | [Y]US6103257 (NISONOFF KEITH [US]) [Y] 5,6,9,11-13 * column 1, lines 6-14, 61-67 * * column 2, lines 1, 19-21,27-29, 46-55 * * column 3, lines 23-26 * * column 6; examples 1,3 *; | [Y]WO0200195 (EPICEPT CORP [US]) [Y] 5,6,9,11-13 * page 2, lines 9-10, 18-27 * * page 3, lines 7-11 ** page 5, lines 23, 26-28 *; | [Y]US2004151771 (GIN JERRY B [US], et al) [Y] 5,6,9,11-13 * page 1, paragraph 1 * * page 2, paragraph 13 * * page 7, paragraph 75 * * page 11; example 11 *; | [Y]US2005152972 (SINGH MOHINDER [US]) [Y] 5,6,9,11-13 * page 1, paragraphs 4, 11 * * page 2, paragraphs 23-25 *; | [Y]US2007031491 (LEVINE HOWARD L [US], et al) [Y] 5,6,9,11-13 * page 1, paragraph 2 * * page 3, paragraphs 21, 22, 30 * * page 6, paragraph 54 *; | [Y]US2009081294 (GIN JERRY B [US], et al) [Y] 5,6,9,11-13 * page 1, paragraphs 5, 7 * * page 3, paragraph 27 * * page 11, paragraphs 94, 97, 99-100 * * page 12, paragraph 107 *; | [Y]US2010247453 (JONES THOMAS L [US]) [Y] 5,6,9,11-13 * page 1, paragraphs 2, 4, 6, 9, 10 * * page 2, paragraphs 11,22 * * page 3; example 1 *; | [XY] - M.V. BERNARDO ET AL, "Sustained release of bupivacaine from devices based on chitosan", IL FARMACO, (20030918), vol. 58, no. 11, pages 1187 - 1191, XP002679132 [X] 1-4,7,8,10,14-16 * abstract * [Y] 5,6,9,11-13 DOI: http://dx.doi.org/10.1016/S0014-827X(03)00192-7 | Examination | - RAJESH V. LALLA ET AL, "Management of Oral Mucositis in Patients Who Have Cancer", DENTAL CLINICS OF NORTH AMERICA., US, (20080101), vol. 52, no. 1, doi:10.1016/j.cden.2007.10.002, ISSN 0011-8532, pages 61 - 77, XP055265041 DOI: http://dx.doi.org/10.1016/j.cden.2007.10.002 | by applicant | US5399354 | US6194003 | WO2004070017 | WO2007110871 | WO2009042969 | WO2009042968 | - STRICHARTZ, ANESTH. ANALG., (1990), vol. 71, pages 158 - 170 | - T. HUNG; V. MOORE-GILLON; J. HERN; A. HINTON; N. PATEL, "Topical bupivacaine in paediatric day-case tonsillectomy: a prospective randomized controlled trial", THE JOURNAL OF LARYNGOLOGY & OTOLOGY, (2002), vol. 116, doi:doi:10.1258/0022215021910311, pages 33 - 36, XP008145307 DOI: http://dx.doi.org/10.1258/0022215021910311 |